Boston Research & Management Inc Abbott Laboratories Transaction History

Boston Research & Management Inc

  • $426 Million
  • Q3 2024

A detailed history of Boston Research & Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Boston Research & Management Inc holds 62,390 shares of ABT stock, worth $7.07 Million. This represents 1.67% of its overall portfolio holdings.

Number of Shares
62,390
Previous 61,925 0.75%
Holding current value
$7.07 Million
Previous $6.43 Million 10.55%
% of portfolio
1.67%
Previous 1.63%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$100.07 - $118.13 $46,532 - $54,930
465 Added 0.75%
62,390 $7.11 Million
Q2 2024

Aug 13, 2024
BUY
$100.73 - $112.44 $14,202 - $15,854
141 Added 0.23%
61,925 $6.43 Million
Q1 2024

May 14, 2024
BUY
$109.52 - $120.96 $6,680 - $7,378
61 Added 0.1%
61,784 $7.02 Million
Q4 2023

Feb 12, 2024
BUY
$90.19 - $110.4 $120,854 - $147,936
1,340 Added 2.22%
61,723 $6.79 Million
Q3 2023

Nov 13, 2023
BUY
$95.53 - $114.62 $46,809 - $56,163
490 Added 0.82%
60,383 $5.85 Million
Q2 2023

Aug 01, 2023
BUY
$100.78 - $112.29 $30,133 - $33,574
299 Added 0.5%
59,893 $6.53 Million
Q1 2023

May 10, 2023
BUY
$96.86 - $114.01 $57,147 - $67,265
590 Added 1.0%
59,594 $6.03 Million
Q4 2022

Feb 13, 2023
SELL
$95.06 - $111.52 $203,428 - $238,652
-2,140 Reduced 3.5%
59,004 $6.48 Million
Q3 2022

Nov 14, 2022
BUY
$96.76 - $112.03 $233,675 - $270,552
2,415 Added 4.11%
61,144 $5.92 Million
Q2 2022

Aug 11, 2022
BUY
$102.07 - $123.37 $68,897 - $83,274
675 Added 1.16%
58,729 $6.38 Million
Q1 2022

May 12, 2022
SELL
$114.02 - $139.04 $136,481 - $166,430
-1,197 Reduced 2.02%
58,054 $6.87 Million
Q4 2021

Feb 10, 2022
SELL
$115.53 - $141.46 $13,285 - $16,267
-115 Reduced 0.19%
59,251 $8.34 Million
Q3 2021

Nov 10, 2021
BUY
$116.66 - $129.06 $320,231 - $354,269
2,745 Added 4.85%
59,366 $7.01 Million
Q3 2021

Nov 10, 2021
SELL
$116.66 - $129.06 $271,234 - $300,064
-2,325 Reduced 3.94%
56,621 $6.79 Million
Q2 2021

Aug 11, 2021
BUY
$105.79 - $124.53 $245,961 - $289,532
2,325 Added 4.11%
58,946 $6.83 Million
Q1 2021

May 11, 2021
SELL
$108.84 - $128.23 $114,282 - $134,641
-1,050 Reduced 1.82%
56,621 $6.79 Million
Q4 2020

Feb 09, 2021
SELL
$105.0 - $114.42 $20,580 - $22,426
-196 Reduced 0.34%
57,671 $6.31 Million
Q3 2020

Nov 09, 2020
SELL
$91.64 - $111.29 $215,170 - $261,308
-2,348 Reduced 3.9%
57,867 $6.3 Million
Q2 2020

Aug 10, 2020
SELL
$76.57 - $98.0 $12,710 - $16,268
-166 Reduced 0.27%
60,215 $5.51 Million
Q1 2020

May 08, 2020
SELL
$62.82 - $91.86 $22,363 - $32,702
-356 Reduced 0.59%
60,381 $4.76 Million
Q4 2019

Feb 07, 2020
SELL
$78.51 - $87.4 $19,627 - $21,850
-250 Reduced 0.41%
60,737 $5.28 Million
Q3 2019

Nov 12, 2019
SELL
$81.84 - $88.74 $74,883 - $81,197
-915 Reduced 1.48%
60,987 $5.1 Million
Q2 2019

Aug 07, 2019
SELL
$72.88 - $85.0 $53,931 - $62,900
-740 Reduced 1.18%
61,902 $5.21 Million
Q1 2019

May 07, 2019
SELL
$66.22 - $80.06 $199,322 - $240,980
-3,010 Reduced 4.58%
62,642 $5.01 Million
Q4 2018

Feb 06, 2019
BUY
$65.56 - $74.27 $494,978 - $560,738
7,550 Added 12.99%
65,652 $4.75 Million
Q3 2018

Nov 13, 2018
BUY
$60.81 - $73.36 $9,121 - $11,004
150 Added 0.26%
58,102 $4.26 Million
Q2 2018

Jul 30, 2018
SELL
$57.57 - $63.54 $65,629 - $72,435
-1,140 Reduced 1.93%
57,952 $3.53 Million
Q1 2018

May 09, 2018
BUY
$56.27 - $63.62 $33,199 - $37,535
590 Added 1.01%
59,092 $3.54 Million
Q4 2017

Feb 09, 2018
SELL
$53.68 - $57.47 $145,204 - $155,456
-2,705 Reduced 4.42%
58,502 $3.34 Million
Q3 2017

Nov 09, 2017
BUY
$48.06 - $53.64 $2.94 Million - $3.28 Million
61,207
61,207 $3.27 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $198B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Boston Research & Management Inc Portfolio

Follow Boston Research & Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Research & Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Boston Research & Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email